Elvia Cowan
SVP, Finance & CAO · 7 filings · Latest: Oct 5, 2026
Vaxcyte, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
PCVX | Elvia Cowan | SVP, Finance & CAO | Oct 5, 2026 | Sale | $86.74 | 19,000 | $1.6M | 27,860 | |
PCVX | Elvia Cowan | SVP, Finance & CAO | Oct 5, 2026 | Option Exercise | $25.92 | 19,000 | $492.5K | 46,860 | |
PCVX | Cowan Elvia | — | Oct 5, 2026 | Proposed Sale | $86.74 | 19,000 | $1.6M | — | |
PCVX | Elvia Cowan | SVP, Finance & CAO | Apr 7, 2026 | Sale | $60.00 | 3,000 | $180.0K | 28,975 | |
PCVX | Elvia Cowan | SVP, Finance & CAO | Apr 7, 2026 | Option Exercise | $25.92 | 3,000 | $77.8K | 31,975 | |
PCVX | Cowan Elvia | — | Apr 7, 2026 | Proposed Sale | $60.00 | 3,000 | $180.0K | — | |
PCVX | Elvia Cowan | SVP, Finance & CAO | Mar 17, 2026 | Sale | $55.57 | 1,892 | $105.1K | 28,975 | |
PCVX | Cowan Elvia | — | Mar 17, 2026 | Proposed Sale | $55.89 | 1,892 | $105.7K | — | |
PCVX | Elvia Cowan | SVP, Finance & CAO | Mar 11, 2026 | Sale | $58.59 | 2,500 | $146.5K | 30,867 | |
PCVX | Elvia Cowan | SVP, Finance & CAO | Mar 11, 2026 | Option Exercise | $25.92 | 2,500 | $64.8K | 33,367 | |
PCVX | Cowan Elvia | — | Mar 11, 2026 | Proposed Sale | $58.62 | 2,500 | $146.6K | — | |
PCVX | Elvia Cowan | SVP, Finance & CAO | Feb 26, 2026 | Option Exercise | $25.92 | 7,716 | $200.0K | 31,931 | |
PCVX | ELVIA COWAN | — | Dec 23, 2025 | Proposed Sale | $47.92 | 11,623 | $557.0K | — | |
PCVX | Cowan Elvia | — | Sep 3, 2024 | Proposed Sale | $107.67 | 5,000 | $538.4K | — |